9/05/2023 12:36:46 PM | Source: LKP Securities Ltd
View on Mankind Pharma IPO from S Ranganathan, LKP Securities
Below is View on Mankind Pharma IPO by S Ranganathan, Head of Research at LKP Securities
Fast Growing India Centric Mankind Pharma truly deserves credit for bringing back life into the Primary Market during CY 2023 with a stellar listing which provided a 30% return to Retail Investors and the icing on the cake was the allotment itself wherein almost all retail investors were allotted the shares.
Above views are of the author and not of the website kindly read disclaimer
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Kalyan Jewellers India gains on reporting 36% rise i...
Larsen & Toubro soars on reporting 23% rise in Q4 co...
Sula Vineyards gains on getting nod to make investme...
Senores Pharmaceuticals gains on inking agreement to...
Titan Company surges on reporting 13% rise in Q4 con...
KSB gains on bagging export order from KSB SE, Germany
BRG Infra rises on securing infrastructure developme...
Mayur Uniquoters leads the gainers of group B on BSE
China Copper Stocks to Decline Further, Boosting Pri...
Ideaforge Technology leads the gainers of group A on...
More News
News Not Found